Consensus recommendations for management of head and neck cancer in Asian countries: a review of international guidelines
- PMID: 23830839
- DOI: 10.1016/j.oraloncology.2013.05.010
Consensus recommendations for management of head and neck cancer in Asian countries: a review of international guidelines
Abstract
Head and neck cancer (HNC) is a disease of the upper aerodigestive tract and is one of the most frequently diagnosed cancers worldwide. A high rate of cancers involving the head and neck are reported across the Asian region, with notable variations between countries. Disease prognosis is largely dependent on tumor stage and site. Patients with early stage disease have a 60-95% chance of cure with local therapy. Early diagnosis and appropriate treatment are important to increase the likelihood of cure and survival. However, the majority of patients present with locally advanced disease and require multimodality treatment. This necessitates, a multidisciplinary approach which is essential to make appropriate treatment decisions, particularly with regards to tolerability, costs, available infrastructure and quality of life issues. Unfortunately, majority of the studies that dictate current practice have been developed in the west where diseases biology, patient population and available infrastructure are very different from those in the Asian continent. With this in mind an expert panel of Head and Neck Oncologists was convened in May 2012 to review the National Comprehensive Cancer Network (NCCN) and the European Society for Medical Oncology (ESMO) clinical practice guidelines and develop practical recommendations on the applicability of these guidelines on the management of head and neck cancer for Asian patients. The objective of this review and consensus meeting was to suggest revisions, to account for potential differences in demographics and resources, to the NCCN and ESMO guidelines, to better reflect current clinical management of head and neck cancer within the Asian region for health care providers. These recommendations, which reflect best clinical practice within Asia, are expected to benefit practitioners when making decisions regarding optimal treatment strategies for their patients.
Keywords: Asia; Guidelines; Head and neck cancer.
Copyright © 2013 The Authors. Published by Elsevier Ltd.. All rights reserved.
Similar articles
-
Indian clinical practice consensus guidelines for the management of squamous cell carcinoma of head and neck.Indian J Cancer. 2020 Feb;57(Supplement):S1-S5. doi: 10.4103/0019-509X.278971. Indian J Cancer. 2020. PMID: 32167063 Review.
-
Multidisciplinary management of head and neck cancer: First expert consensus using Delphi methodology from the Spanish Society for Head and Neck Cancer (part 1).Oral Oncol. 2017 Jul;70:58-64. doi: 10.1016/j.oraloncology.2017.04.004. Epub 2017 Apr 17. Oral Oncol. 2017. PMID: 28427761 Review.
-
Multidisciplinary management of head and neck cancer: First expert consensus using Delphi methodology from the Spanish Society for Head and Neck Cancer (part 2).Oral Oncol. 2017 Jul;70:65-72. doi: 10.1016/j.oraloncology.2017.04.005. Epub 2017 Apr 17. Oral Oncol. 2017. PMID: 28427762 Review.
-
Pan-Asian adaptation of the EHNS-ESMO-ESTRO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with squamous cell carcinoma of the head and neck.ESMO Open. 2021 Dec;6(6):100309. doi: 10.1016/j.esmoop.2021.100309. Epub 2021 Nov 26. ESMO Open. 2021. PMID: 34844180 Free PMC article.
-
Head and Neck Cancer Survivorship Care Guideline: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Cancer Society Guideline.J Clin Oncol. 2017 May 10;35(14):1606-1621. doi: 10.1200/JCO.2016.71.8478. Epub 2017 Feb 27. J Clin Oncol. 2017. PMID: 28240970 Review.
Cited by
-
The Discovery of Oral Cancer Prognostic Factor Ranking Using Association Rule Mining.Eur J Dent. 2024 Jul;18(3):907-917. doi: 10.1055/s-0043-1777050. Epub 2024 May 14. Eur J Dent. 2024. PMID: 38744326 Free PMC article.
-
Changes in the Incidence and Human Papillomavirus-Positive Portion of Oropharyngeal Squamous Cell Carcinoma in Hong Kong.Cancers (Basel). 2024 Jan 3;16(1):226. doi: 10.3390/cancers16010226. Cancers (Basel). 2024. PMID: 38201653 Free PMC article.
-
Definitive Surgery after Neoadjuvant Chemotherapy for Locally Advanced Oral Cavity Cancers: Experience from a Tertiary Care Center.South Asian J Cancer. 2023 Apr 10;12(4):341-348. doi: 10.1055/s-0043-1768038. eCollection 2023 Oct. South Asian J Cancer. 2023. PMID: 38130286 Free PMC article.
-
Imaging for Laryngeal Malignancies: Guidelines for Clinicians.Indian J Otolaryngol Head Neck Surg. 2023 Dec;75(4):3386-3395. doi: 10.1007/s12070-023-03986-w. Epub 2023 Jun 23. Indian J Otolaryngol Head Neck Surg. 2023. PMID: 37974698
-
Squamous Cell Carcinoma of the Oral Cavity, Oropharynx, and Larynx: A Scoping Review of Treatment Guidelines Worldwide.Cancers (Basel). 2023 Sep 3;15(17):4405. doi: 10.3390/cancers15174405. Cancers (Basel). 2023. PMID: 37686681 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical